tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MaxCyte Experiences Shift in Major Holdings by BlackRock
Company AnnouncementsMaxCyte Experiences Shift in Major Holdings by BlackRock
9d ago
MXCT
BlackRock Increases Stake in MaxCyte to 7.66%
PremiumCompany Announcements
BlackRock Increases Stake in MaxCyte to 7.66%
10d ago
MXCT
BlackRock Adjusts Holdings in MaxCyte, Inc.
PremiumCompany Announcements
BlackRock Adjusts Holdings in MaxCyte, Inc.
10d ago
MXCT
MaxCyte enters strategic platform license with TG Therapeutics
PremiumThe Fly
MaxCyte enters strategic platform license with TG Therapeutics
11d ago
DTIL
MXCT
MaxCyte Partners with TG Therapeutics for Autoimmune Cell Therapy
PremiumCompany Announcements
MaxCyte Partners with TG Therapeutics for Autoimmune Cell Therapy
11d ago
MXCT
MaxCyte to Announce 2024 Financial Results and Engage in Key Investor Conference
PremiumCompany AnnouncementsMaxCyte to Announce 2024 Financial Results and Engage in Key Investor Conference
16d ago
MXCT
MaxCyte Expands Stock Capital with New Common Stock Issuance
Premium
Company Announcements
MaxCyte Expands Stock Capital with New Common Stock Issuance
19d ago
MXCT
MaxCyte Announces Executive Stock Transaction
Premium
Company Announcements
MaxCyte Announces Executive Stock Transaction
23d ago
MXCT
MaxCyte acquires SeQure Dx for $4.5M at closing, sees accretion
PremiumThe Fly
MaxCyte acquires SeQure Dx for $4.5M at closing, sees accretion
24d ago
MXCT
MaxCyte Expands Cell Engineering Capabilities with Acquisition of SeQure Dx
PremiumCompany Announcements
MaxCyte Expands Cell Engineering Capabilities with Acquisition of SeQure Dx
24d ago
MXCT
BlackRock Increases Stake in MaxCyte, Inc.
PremiumCompany Announcements
BlackRock Increases Stake in MaxCyte, Inc.
25d ago
MXCT
MaxCyte Sees Increase in BlackRock Holdings
PremiumCompany Announcements
MaxCyte Sees Increase in BlackRock Holdings
1M ago
MXCT
BlackRock Increases Stake in MaxCyte to 7.57%
PremiumCompany AnnouncementsBlackRock Increases Stake in MaxCyte to 7.57%
1M ago
MXCT
MaxCyte Announces Change in Major Holdings by BlackRock
Premium
Company Announcements
MaxCyte Announces Change in Major Holdings by BlackRock
1M ago
MXCT
BlackRock Increases Stake in MaxCyte, Inc.
Premium
Company Announcements
BlackRock Increases Stake in MaxCyte, Inc.
1M ago
MXCT
MaxCyte sees FY24 revenue $32.2M-$32.4M, consensus $37.9M
PremiumThe Fly
MaxCyte sees FY24 revenue $32.2M-$32.4M, consensus $37.9M
1M ago
MXCT
MaxCyte sees Q4 revenue $8.3M-$8.5M, consensus $7.67M
PremiumThe Fly
MaxCyte sees Q4 revenue $8.3M-$8.5M, consensus $7.67M
1M ago
MXCT
MaxCyte Reports 2024 Financial Growth and Industry Milestones
PremiumCompany Announcements
MaxCyte Reports 2024 Financial Growth and Industry Milestones
1M ago
MXCT
MaxCyte Expands Common Stock Issuance to 105.7 Million Shares
PremiumCompany Announcements
MaxCyte Expands Common Stock Issuance to 105.7 Million Shares
2M ago
MXCT
MaxCyte Director Exercises Stock Options and Executes Sales
PremiumCompany AnnouncementsMaxCyte Director Exercises Stock Options and Executes Sales
2M ago
MXCT
MaxCyte Announces Leadership Transition and Strategic Focus
Premium
Company Announcements
MaxCyte Announces Leadership Transition and Strategic Focus
2M ago
8K
MXCT
MaxCyte Announces Board Member Retirement
Premium
Company Announcements
MaxCyte Announces Board Member Retirement
2M ago
MXCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >